Rope exercise.

Biologics in Rotator Cuff, Meniscus, Cartilage and Osteoarthritis Article

The article entitled “Application of biologics in the treatment of the rotator cuff, meniscus, cartilage, and osteoarthritis” reviewed the current status of the use of platelet-rich plasma, bone marrow aspirate, and stem cells within sports medicine.

What can stem cells do?

There is evidence that these technologies are going to influence the way that orthopaedic surgeons practice medicine, and work at the Andrews Institute is focusing on leading the way but also producing proof that these methods are making a difference in the lives of our patients.

If you have questions about platelet rich plasma, bone marrow aspirate, or stem cells please contact the Gulf Breeze, Florida orthopedic surgeon, Dr. Adam Anz located at the Andrews Institute.

Dr. Anz's Related Blog

3-T MRI mapping is a valid in vivo method of quantitatively evaluating the anterior cruciate ligament: rater reliability and comparison across age

3-T MRI mapping is a valid in vivo method of quantitatively evaluating the anterior cruciate ligament: rater reliability and comparison across age

As biologic augmentation methods emerge, objective measures of soft tissues are necessary for developmental study. The purpose of this study was to develop a quantitative MRI mapping protocol for the

Articular Cartilage Regeneration With Autologous Peripheral Blood Progenitor Cells and Hyaluronic Acid After Arthroscopic Subchondral Drilling: A Report of 5 Cases With Histology

The purpose of this study was to evaluate the quality of articular cartilage regeneration after arthroscopic subchondral drilling followed by postoperative intraarticular injections of autologous peripheral blood progenitor cells (PBPCs)

A Tensionable and Retensionable Knotless Anchor Repair Construct for Compression After Reduction of Tibial Avulsion Fracture of Anterior Cruciate Ligament

Anterior cruciate ligament (ACL) injuries are on the rise in the pediatric and adolescent patient populations, with incidence rates peaking at age 16 years for female patients and at age